Skip to Content

M 144 (Tamoxifen Citrate 10 mg)

Pill with imprint M 144 is White, Round and has been identified as Tamoxifen Citrate 10 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, metastatic; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 144

Tamoxifen citrate 10 mg M 144 Front
Tamoxifen citrate 10 mg M 144 Back
Tamoxifen citrate 10 mg M 144
Tamoxifen citrate 10 mg M 144

Tamoxifen Citrate

Imprint
M 144
Strength
10 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0144
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M 144"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.